Introduction
oedema, pleural effusions and finally pulmonary oedema, associated with a gain of body weight of 25 kg Minimal-change glomerulonephritis ( MCGN ) is the despite the administration of high doses of loop diurmost frequent cause of nephrotic syndrome in children, etics. A maximum of urinary protein excretion of 62 g while in adults only 25% of all nephrotic syndromes per day was measured. Laboratory tests showed a are caused by MCGN [1 ] . Treatment with steroids reduced serum protein of 37 g/l (normal range causes a partial or complete remission in the large 66-87 g/l ) and a reduced albumin of 24.8 g/l (normal majority of patients with MCGN. Alkylating immunorange 35-52 g/l ). Administration of intravenous albusuppressive drugs such as cyclophosphamide and chlormin to maintain the oncotic pressure was without ambucil have been used with some success in steroideffect. Finally a therapy with chlorambucil (7 mg per resistant patients [1 ] . Although cyclosporin A is very day for 2 weeks, stepwise dose reduction over 2 more effective in the treatment of steroid-dependent MCGN, weeks) in addition to fluocortolone ( 100 mg per day, a remission in steroid-resistant cases can only be stepwise reduction to 20 mg per day over 4 weeks) was achieved in about 60% [2] .
started. During this treatment proteinuria decreased to We report the case of a young woman with a steroid and CsA-resistant nephrotic syndrome due to a min-69 mg per day and the patient was discharged with imal-change glomerulonephritis, who was treated suc-normal serum protein levels and without oedema. cessfully with tacrolimus (FK 506 ).
Seven months later the patient presented at our hospital for the first time.
She had increasing oedema of the face and the legs,
Case report
worsening weakness, nausea and vomiting for 3 days. At the time of presentation the patient was still on a In June 1993 a young woman was referred to our therapy with 20 mg fluocortolone per day. Physical hospital because of the third relapse of a minimal-examination showed a patient with normal weight change nephrotic syndrome. One year previously the (165 cm, 62.6 kg), with regular heart rate and a blood patient had been treated in another hospital because pressure of 120/70 mmHg. The face and the legs were of a nephrotic syndrome with oedema, dyspnoea, mas-oedematous, while no clinical signs of ascites were sive proteinuria and hypoproteinaemia (serum protein evident. The laboratory tests revealed the pattern of a 47 g/l, serum albumin 11.3 g/l ). Under the tentative nephrotic syndrome with the serum protein concentradiagnosis of minimal-change glomerulonephritis a tion lowered to 44.4 g/l, albumin lowered to 16.6 g/l, therapy with 80 mg prednisolone per day was initiated; serum cholesterol elevated to 418 mg%, and a prothis led to a normalization of protein excretion. During teinuria of 15 g per day. Renal function was normal the next 2 months the steroid dose was tapered step-as judged from normal values for creatinine and urea. wise. When reaching a daily dose of 20 mg predniso-Ultrasound investigation revealed kidneys of normal lone the first relapse occurred. Renal biopsy confirmed length and structure, ECG, echocardiography and the diagnosis of minimal-change glomerulonephritis chest X-ray were normal as well. Both laboratory and 80 mg prednisolone again led to an immediate findings and physical examination were not indicative cessation of proteinuria. Another 2 months later, after of vasculitis or rheumatic disease. A renal biopsy tapering steroids to 20 mg prednisolone per day, pro-including an electron-microscopic evaluation conteinuria again became manifest. Even with 150 mg firmed the diagnosis of minimal-change glomeruloprednisolone per day the increasing proteinuria could nephritis without focal or segmental glomerular sclerosis. all relapses had occurred while the patient was still on was reduced to 5 mg per day, and in April 1996 the steroid therapy was stopped completely. Since the a therapy with relative high doses of steroids (= steroid-dependent MCGN ), a combination therapy beginning of the therapy with tacrolimus no more episodes of nausea or vomiting nor other side-effects with cyclosporin (whole blood concentrations of about 100 ng/ml ) and prednisolone was started. Again the have been observed.
In September 1996, after 1 year of treatment with steroid dose was reduced in a stepwise manner and stopped in November 1993. Except for a gastritis with tacrolimus, a further renal biopsy was performed.
Histological findings were consistent with a minimalhaematemesis, no medical problems occurred in the following year, so that the CsA dose was reduced and change glomerulonephritis in complete remission. No signs of tubular damage attributable to cyclosporin, finally stopped as planned to reduce the risk of CsA nephrotoxicity in August 1994. Two weeks after the tacrolimus, or FSGN was seen. Currently the patient feels well and is in excellent physical shape. The cessation of the immunosuppressive therapy the patient developed the fourth relapse, which could be sup-nephrotic syndrome remains in complete remission and the renal function is normal. With a daily dosage of pressed by the immediate restarting of the therapy with cyclosporin and prednisolone. Again plasma creatinine 4 mg tacrolimus a therapeutic whole-blood level of about 5 mg/l is maintained. and urea were in the normal range. During the following year, using this therapy, a complete remission was
The case of this young lady was discussed briefly in a letter to The Lancet [7] . achieved, complicated by nausea and occasional vomiting after taking CsA. In August 1995, with the patient at 27 years of age, the fifth relapse occurred while still Discussion on therapy with CsA, presenting with proteinuria of 8 g/l, an increase of body weight of 10 kg and orthopnoea. An increase of the steroid dosage to 80 mg per The therapeutic strategy in minimal-change nephrotic syndrome comprises steroids, and in steroid-resistant day did not affect the proteinuria and the short-term intravenous administration of 240 mg frusemide in cases cyclosporin, azathioprine, and alkylating agents like cyclophosphamide or chlorambucil [1] [2] [3] . Our addition to 25 mg hydrochlorothiazide p.o. per day led to no mobilization of the oedema. During this high-case documents the successful treatment of steroidand CsA-resistant minimal-change glomerulonephritis dose diuretic therapy an increase of creatinine (to 1.94 mg% (0.5-0.9 mg%)) and urea (to 142 mg% with tacrolimus ( Figure 1) .
Tacrolimus (FK 506 ) is a macrolide antibiotic which ( 10-50 mg%)) was observed for the first time. Because of steroid-and CsA-resistant nephrotic syndrome, CsA is isolated from the fungus Streptomyces tsukubaensis.
Very similar to cyclosporin, tacrolimus has a relatively was replaced by tacrolimus (FK 506 ). With a daily dosage of 6 mg tacrolimus, attaining whole-blood con-selective inhibitory action on CD4 T helper lymphocytes. Although both drugs prolong solid-organ allocentrations of 5-7 mg/l, in combination with a daily dose of 50 mg prednisolone, the proteinuria decreased graft survival, as shown in several studies, tacrolimus seems to have superior immunosuppressive effects within 10 days to normal values; in addition serum creatinine and urea decreased to the normal range [4, 5] . There is evidence from the literature to suggest a superior proteinuria control with tacrolimus comagain. Until December 1995 the dosage of prednisolone
